Joint Symposia

EANM is teaming up again with its external partner societies, to fully reflect the multidisciplinarity of Nuclear Medicine.

A preliminary list of planned joint symposia can be found hereunder. The partner societies will be published after finalization of the corresponding session.

 

Joint Symposium 1
Bone & Joint + Inflammation & Infection + Paediatrics Committee / ESSR
PET/MRI in MSK – Be Hybrid!

SESSION DETAILS

 

 

Joint Symposium 2
Cardiovascular Committee / ASNC
PET-MPI vs. SPECT-MPI – Is it Worth the Price?

SESSION DETAILS

 

 

Joint Symposium 3
Cardiovascular Committee / EACVI
MPI after the ISCHEMIA Trial – Still Alive?

SESSION DETAILS

 

 

Joint Symposium 4
Dosimetry Committee / CIRSE
Biokinetics and Dosimetry in Intraarterial Therapy

SESSION DETAILS

 

 

Joint Symposium 5
Drug Development + Radiopharmacy + Oncology & Theranostics Committee / SRS
Targeting Cancer with Peptides, Fragments or Antibodies

SESSION DETAILS

 

 

Joint Symposium 6
Drug Development + Radiopharmacy + Translational Molecular Imaging & Therapy Committee / SRS
Modifying Radiopharmaceuticals to Alter Pharmacokinetics

SESSION DETAILS

 

 

Joint Symposium 7
Inflammation & Infection Committee / EASD
My Foot is on Fire – Find the Hot Spot

SESSION DETAILS

 

 

Joint Symposium 8
Inflammation & Infection + Bone & Joint Committee / EULAR
PET/CT and PET/MRI in Patients with Autoimmune Disorders

SESSION DETAILS

 

 

Joint Symposium 9
Neuroimaging Committee / EAN
The New ATN Diagnostic Concept in Alzheimer’s Disease

SESSION DETAILS

 

 

Joint Symposium 10
Neuroimaging Committee / ILAE
PET/MRI in Epilepsy

SESSION DETAILS

 

 

Joint Symposium 11
Neuroimaging + Oncology & Theranostics Committee / EANO
Advancements in Neuro-Oncology

SESSION DETAILS

 

 

Joint Symposium 12
Oncology & Theranostics Committee / EORTC
Nuclear Medicine in Precision Oncology

SESSION DETAILS

 

 

Joint Symposium 13
Oncology & Theranostics Committee / EHA
Biomarkers in Lymphoma

SESSION DETAILS

 

 

Joint Symposium 14
Oncology & Theranostics Committee / EHA
New Therapies in Lymphoma – Is Deauville Still Good Enough?

SESSION DETAILS

 

 

Joint Symposium 15
Oncology & Theranostics Committee / EHA
Imaging Challenges in Multiple Myeloma – Quo Vadis 2021?

SESSION DETAILS

 

 

Joint Symposium 16
Oncology & Theranostics Committee / ESMO
Combination Treatments – What can Radioligand Therapy be Combined with?

SESSION DETAILS

 

 

Joint Symposium 17
Oncology & Theranostics Committee / EAU
What to Do and Not Do in Prostate Imaging

 

Joint Symposium 18
Oncology & Theranostics Committee / EAU
Urological Challenges for Imaging Beyond Prostate

SESSION DETAILS

 

 

Joint Symposium 19
Physics Committee / EFOMP
Harmonisation and Standardisation

SESSION DETAILS

 

 

Joint Symposium 20
Physics Committee / AAPM
Artificial Intelligence for Image Processing and Quantification

SESSION DETAILS

 

 

Joint Symposium 21
Physics Committee / AAPM
Numerical and Computer Phantoms

SESSION DETAILS

 

 

Joint Symposium 22
Radiation Protection + Thyroid + Dosimetry Committee / TBA
The MEDIRAD Project – Impact on Nuclear Medicine Practice

 

Joint Symposium 23
Radiation Protection + Technologist Committee / EURADOS
Extremity Dosimetry – It’s in Your Hands!

SESSION DETAILS

 

 

Joint Symposium 24
Thyroid + Oncology & Theranostics Committee / ESMO
Theranostics in Thyroid Cancer Beyond Radioactive Iodine

SESSION DETAILS

 

 

Joint Symposium 25
Thyroid Committee / ESES / ESSO
Global Cost-Effectiveness of Different DTC Management Strategies

SESSION DETAILS

 

 

Joint Symposium 26
Translational Molecular Imaging & Therapy Committee / ESMI / WMIS
Imaging Mitochondria and Mitochondrial Dysfunction

SESSION DETAILS

 

 

Joint Symposium 27
Neuroimaging Committee / JSNM
Advances in Molecular Imaging of Neurodegenerative Disorders

SESSION DETAILS